UNSPSC 51422366: Prednisolone steaglate

This classification denotes a therapeutic glucocorticoid with the molecular formula C41H64O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OZQ2XN817F, chemically known as stearate ester of 11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione-21-glycolate but more generally known as prednisolone steaglate, which bears US NIH Compound Identifier 71206. European Medicines Agency schedules Prednisolone steaglate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10019MIG.

UNSPSC 51422366 Prednisolone steaglate is a Commodity code for a specific pharmaceutical product, yet the single recent state and local opportunity associated with it—Seminole County, Florida's IFB for naloxone and drug deactivation systems—bears no relationship to prednisolone steaglate procurement. The mismatch suggests either a data-entry error in the opportunity tagging or that this code sees minimal or no actual activity in state and local procurement right now. The sourced opportunity involves naloxone kits and safe drug deactivation equipment, not corticosteroid formulations, and falls outside the scope of this commodity code.

No recent state and local solicitations for prednisolone steaglate appear in the available data. The single tagged opportunity addresses a different pharmaceutical category entirely (opioid overdose reversal and drug disposal), and the due date (July 26, 2023) is significantly outdated relative to the current date. Without evidence of active procurement demand under this code in state and local markets, there is insufficient basis to characterize issuing-body mix, geographic concentration, or forward opportunity volume.